Galectin-3 cleavage as a marker for matrix metalloproteinase activity in cancer
Provided are differential antibodies recognizing the cleaved and non-cleaved forms of matrix metalloproteinases (MMPs), and methods of using the antibodies as surrogate diagnostic markers for the presence of active MMPs in cancer, such as growing breast cancers.
RAZ AVRAHAM [US]; NANGIA-MAKKER PRATIMA [US]; FRIDMAN RAFAEL [US]
Type of Offer:
« More Biotech Patents